News
Morepen Labs starts production of test batch of Sputnik V vaccine
Morepen Laboratories has started production of the test batch of Russia's Sputnik V Covid-19 vaccine at its facility in Himachal Pradesh, Russian Direct Investment...
Drug Research
BioMed X and Merck KGaA, Darmstadt, Germany launch new research program in oncology
BioMed X, a leading independent research institute, announced the start of its eighth joint research program with Merck KGaA, Darmstadt, Germany. The new program...
Press Releases
Univercells Technologies and VectorBuilder announce strategic partnership for optimized custom viral vector production
Univercells Technologies, a provider of novel biomanufacturing technologies for flexible and scalable viral vector production, has formed a worldwide strategic partnership with VectorBuilder, a...
Clinical Trials
Bharat Biotech concludes final analysis for Covaxin efficacy from phase 3 clinical trials
Bharat Biotech, a global leader in vaccine development and innovation, announced safety and efficacy analysis data from Phase III clinical trials of COVAXINยฎ, a...
Drug Research
Recipharm signs Memorandum of Understanding (MOU) for the fill finish of vaccines and biotherapeutics in Morocco
Global contract development and manufacturing organisation (CDMO), Recipharm, has signed an MOU, along with His Majesty the King of Morocco, Mohammed VI, the Moroccan...
News
Tech Mahindra partners StaTwig for blockchain-based traceability solution for vaccine supply chain
IT major Tech Mahindra said it has partnered with StaTwig, a Singapore and Hyderabad-based digital supply chain solution provider, to implement vaccine traceability platform...
Drug Research
GSK and Alector to develop antibodies for neurodegenerative diseases
GlaxoSmithKline plc and Alector announced a strategic global collaboration for the development and commercialisation of two clinical-stage, potential first-in-class monoclonal antibodies (AL001 and AL101)...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
















